Privacy Policy & Cookies

Road Accident Claims Work Accident Claims Asbestos Exposure Claims Industrial Disease Claims Head and Brain Injury Claims Medical Negligence Claims Surgical Error Claims Travel Accident Claims Military Accident Claims Personal Injury Claims

How much?

FAQ

PI Information

Our PI Lawyers

0800 783 90190800 783 9019
0330 333 56560330 333 5656
Claim OnlineClaim Online
Text CLAIM to 82010 now, standard network rates applyText CLAIM to 82010
Network of offices throughout the UKVisit our UK offices

We'll call you back

Leave your details and we'll call you back between 8am and 8pm Monday to Friday, or between 9am and 5pm on Saturdays.

Name:

Best contact no:

Best contact time:


Home > News > Personal Injury News

28th August 2006

Alimta Drug Campaign Debated in Parliament

An ongoing campaign for the cancer drug Alimta to be made available on the NHS has been taken to the Secretary of State, Patricia Hewitt. Alimta can extend the life expectancy of some patients suffering from mesothelioma, which is an incurable form of cancer strongly linked to asbestos exposure. Campaigners for the drug argue that it should be made permanently available on the NHS after a trial period has been brought to an end.

The Secretary of State for Health has been asked to investigate the issue after David Anderson, MP for Blaydon raised the matter in Parliament.

Clear Answers expert mesothelioma solicitors backed a campaign in the Newcastle Evening Chronicle calling for the drug to be made available on the NHS in the North East of England. The campaign was successful, however the drug is to be withdrawn from prescription on the NHS following a review by the National Institute for Clinical Excellence (NICE).

As a result Under Secretary of State for the Department of Constitutional Affairs, Bridget Prentice, has urged Patricia Hewitt investigate the issue.

In a letter to Miss Hewitt, Mrs Prentice said: "On Tuesday, whilst taking oral questions on the floor of the house, David Anderson raised with me issues concerning the use of the drug Alimta and in particular asking me to raise with you his request that NICE lift the limits on the use of the drug. I do have a lot of sympathy with the work being done by many of our colleagues in this area and would be grateful if you would arrange for a reply to be sent to David letting him know what the position is."

Alimta Can Extend Life Expectancy

Alimta is not a cure for mesothelioma but it can extend the period of survival for some patients and could help a significant number of people cope with the disease.

Head of asbestos litigation for Clear Answers' lawyers Thompsons Solicitors

Ian McFall said: 'It is encouraging that this issue is now before the Secretary of State for Health. I hope Ms Hewitt looks at the matter closely and comes to a decision which may give hope to hundreds of mesothelioma sufferers. I would urge Ms Hewitt to use her authority to allow doctors to prescribe Alimta on the NHS to any mesothelioma patients who they believe could benefit from this treatment.

Compensation Claim

Clear Answers' lawyers specialising in mesothelioma and other asbestos-related diseases are able to offer further guidance on likely damages to anyone suffering from an asbestos-related illness, to the families of sufferers, or to anyone who suspects that they or a member of their family may be suffering from, or may have suffered from a work-related asbestos disease.

Telephone us now on 0800 783 9019 or complete one of our online claim enquiry forms.

back to news index

print this page